Navigation Links
Neiker-Tecnalia finds genetic material to counter 'pitch canker' and 'pine wilt'
Date:11/11/2011

ge of Forestry Health at Neiker-Tecnalia, and Dr. Gustavo Renobales from the University of the Basque Country (UPV/EHU). The fungi Diplodia pinea and Fusarium circinatum were inoculated into the 15 species of conifers analysed. The most resistant were the Sequoia type - Sequoia sempervirens and Sequoiadendron giganteum- and the pine of the Pinus taeda species. The most vulnerable turned out to be Pinus radiata.

958 forest zones analysed

The Diplodia pinea fungus is distributed over most part of pine plantations in Euskadi, according to the research. Out of a total of 958 forest zones studied, the fungus was detected in 817 of them. The disease caused by it 'pine wilt' produces the wilting of buds and the appearance of cankers (breaks in the tree's tissues) and deformations in trunks and branches, besides causing a bluish colouration of the part of the wood exposed to the air.

As regards its geographical distribution, the highest levels of infection by Diplodia pinea have been found in zones affected by hail or strong winds over the last ten years. With this data, Neiker-Tecnalia proposes that plantations of pinus radiata, the most vulnerable species, should not be undertaken in those areas with these climatic conditions, given that strong winds and hail cause damage to the trees and whereby the fungus enters.

`Pine wilt' greatly reduces the capacity for growth of the trees and can even end their lives. To this can be added the fact that timber of the affected individuals lose quality due to the deformations caused in the trunks.

Pitch canker favoured by rainfall

In the case of Fusarium circinatum, this is much less widespread and appears almost exclusively in the forest masses of pinus radiata located in the north-east of Gipuzkoa and in two large areas in the centre of Bizkaia. Of the 958 wooded zones studied, this fungus appears in
'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Neiker-Tecnalia participates in a European project for improving the welfare of farm animals
2. Neiker-Tecnalia research -- to obtain more productive, resistant and sustainable oil palms
3. Neiker-Tecnalia creates air-conditioned greenhouse with alternative energies
4. Neiker-Tecnalia makes progress in detection and prevention of infection by visna maedi virus
5. Neiker-Tecnalia confirms need to undertake epidemiological monitoring programs for ticks
6. Neiker-Tecnalia study use of oilseedrape and sunflower oils to produce fuel and feed for herds
7. Neiker-Tecnalia underlines the need to maintain programs for monitoring pathogens in wildlife
8. UC research finds that a ducks boon might be a turtles bane
9. Drying intensifying wildfires, carbon release ninefold, study finds
10. Prehistoric greenhouse data from ocean floor could predict earths future, MU study finds
11. UM School of Medicine finds new pathway critical to heart arrhythmia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ... to expand its team and bring LaunchKey to market ...
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ... flexible and robust – with the clinical data to ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Humans are having an effect on Earth,s ecosystems but it,s ... the planet we are causing. Now you can add an ... The only question is how large of an impact will ... issue of Science (Dec. 16, 2011), Arizona State ...
... Ill. Clinical gene therapy may be one step closer, ... molecules. A group of University of Illinois researchers, led ... short spiral-shaped proteins can efficiently deliver DNA segments to cells. ... Chemie. "The main idea is these are new ...
... identified a gene mutation that researchers estimate dates back to ... yet discovered. , Researchers with the Ohio State University Comprehensive ... J. Solove Research Institute led the study and estimate that ... ago. Only a mutation seen in cystic fibrosis that arose ...
Cached Biology News:Researchers assess effects of a world awash in nitrogen 2Let's do the twist: Spiral proteins are efficient gene delivery agents 2Let's do the twist: Spiral proteins are efficient gene delivery agents 3Scientists discover second-oldest gene mutation 2
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... Xeno Diagnostics has again received an ... COLA inspection. Xeno has met all criteria for ... organization. Accreditation is earned only by laboratories that ... demonstrate continued accuracy in the performance of proficiency ... , While the Laboratory Excellence award ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... Legislature are bogged down in a budget fight, just like ... is in Wisconsin. But there's an important distinction between the ... the few areas of agreement, not a source of perpetual ... and Governor Tim Pawlenty are behind schedule in most ways ...
... Congress as well as the Wisconsin Legislature, it is becoming ... research to persuade fellow lawmakers that such science is unethical. ... public opinion about its relative merits is beginning to carry ... of life and the promise of science, the House of ...
... could offer treatment for the underlying process not ... second Governor's Business Plan Contest on Tuesday, ... , ,Mithridion, a University of Wisconsin-Madison spinoff, emerged as ... for the judges. Even before that, co-founder Jeff Johnson, ...
Cached Biology Technology:Feuds between UW and the Legislature should end for good of the state 2Feuds between UW and the Legislature should end for good of the state 3With ethics guidelines, political consensus emerging on stem-cell research 2With ethics guidelines, political consensus emerging on stem-cell research 3Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 2Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 3Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 4
... SAGE (serial analysis of gene ... expression analysis. Expression profiles generated ... to detect low-abundance transcripts making ... genes. The I-SAGE Kit is ...
Human LAIR2 Biotinylated Affinity Purified PAb...
... mycobacteria in Complete Freund's adjuvant attract macrophages ... which enhances the immuneresponse. For this reason, ... the initial injections; Incomplete Freund's adjuvant is ... in saline) are typically mixed with an ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
Biology Products: